• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Archives for May 2018

50 Years Of Global Health Progress – Interview With IFPMA Head Thomas Cueni

23/05/2018 by William New, Intellectual Property Watch Leave a Comment

Dr Tedros Adhanom Ghebreyesus, WHO Director-General in his inaugural speech at the World Health Assembly this week, explained that partnerships are a key strategy for the WHO to ensuring healthy lives and promoting well-being for all at all ages. He added that the WHO is engaging with the private sector as a crucial partner in achieving health for all. Thomas Cueni, IFPMA’s Director General, in an interview with Health Policy Watch on the occasion of the IFPMA’s 50-year anniversary, explains how the research-based biopharmaceutical industry together with IFPMA have contributed to the huge strides in health progress over 50 years. He explains the major leaps forward, setbacks and mistakes, as well as how industry is part of the solution, as “do-ers” and partners in global health progress. Cueni also talks about pricing and cost of R&D.

Filed Under: IP Policies, Language, Themes, Venues, English, Europe, Health Policy Watch, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, Regional Policy, WHA 2018, WHO

World Health Assembly Begins Discussion On Access To Medicines

22/05/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment

On the second day of this week’s annual World Health Assembly, delegates began discussing the issue of “shortages of, and access to, medicines and vaccines.” It is generally held that access to safe, efficacious, and affordable medicines is of paramount importance to achieve the United Nations Sustainable Development Goals by 2030, but there seems to be no expeditious solution, and no lack of divergent views on how to get there.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Development, English, Health & IP, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, WHA 2018, WHO

Global Antimicrobial Resistance R&D Hub Launched At Health Assembly

22/05/2018 by Damilola Adepeju for Intellectual Property Watch Leave a Comment

Countries, organisations and foundations came together today alongside the annual World Health Assembly to launch the Global Antimicrobial Resistance and Development Hub (Global AMR R&D Hub).

Filed Under: IP Policies, Language, Themes, Venues, English, Finance, Patents/Designs/Trade Secrets, WHA 2018, WHO

Taiwan Left At Health Assembly Door; Police Ask Activists To Remove Political T-Shirts

22/05/2018 by Intellectual Property Watch 1 Comment

For the second year in a row, Taiwan has not been invited to participate as an observer at the World Health Assembly taking place this week. Political dissent with China borne out of a change of government in Taiwan now refusing to recognise the “One China” principle resulted in Taiwan being left out of the World Health Organization. At the opening of the Assembly, several countries supported Taiwan, including the United States.

Filed Under: IP-Watch Briefs, Language, Themes, Venues, English, Human Rights, United Nations - other, WHA 2018, WHO

O Paradoxo Das Patentes No Brasil E Suas Implicações Para O Acesso A Medicamentos

22/05/2018 by Intellectual Property Watch 2 Comments

O sistema de patentes foi supostamente projetado para permitir a recuperação do investimento em pesquisa e desenvolvimento (P&D) de um novo produto, através da venda sob exclusividade por um período de tempo. Vários estudos relacionaram preços altos de medicamentos à situação de monopólio estabelecida pelo sistema de patentes e outros direitos de monopólio (como a exclusividade de dados). É bastante estabelecido que a existência de uma patente pode levar a preços altos devido à condição de mercado em que um produtor pode operar com exclusividade. Vários estudos relacionaram preços elevados de medicamentos à situação de monopólio estabelecida pelo sistema de patentes e outros direitos de monopólio (como a exclusividade de dados). Na ausência de concorrência, um produtor pode cobrar praticamente qualquer preço pelo seu produto. A concorrência, portanto, pode promover uma redução significativa de preços e aumentar o acesso.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Health & IP, Human Rights, Innovation/ R&D, Latin America/Caribbean, Patents/Designs/Trade Secrets, Regional Policy, Technical Cooperation/ Technology Transfer

US Patent System Remains 1st In The World, Despite Errors In Chamber Rankings

21/05/2018 by Intellectual Property Watch 1 Comment

Over the past few months, US officials ranging from PTO Director Andrei Iancu to a number of Congressional members, most recently Rep. Kelly (Illinois-2), have cited to the Chamber of Commerce’s ranking of intellectual property systems, which has dropped the US patent system from 1st in the world to 12th. They cite the rankings as evidence that the US patent system is in urgent need of review.

Unfortunately, the rankings are based on misinterpretations and falsehoods. These are worth noting ahead of a House Judiciary hearing Tuesday with Iancu testifying.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, English, Innovation/ R&D, North America, Patents/Designs/Trade Secrets, Regional Policy

WHO Director Dr Tedros Opens First Annual World Health Assembly With ‘Keys For Success’

21/05/2018 by Catherine Saez, Intellectual Property Watch 1 Comment

World Health Organization Director General Tedros Adhanom Ghebreyesus (“Dr Tedros”) in his first speech in his function at head of the World Health Assembly described three keys to reach the ambitious goals of the organisation. He envisioned a transformed WHO helped by a strong leadership team, called for political commitment for which he said most country leaders are ready, and advocated partnerships with a number of international health actors, including the private sector.

Filed Under: IP Policies, Language, Themes, Venues, English, Health & IP, Health Policy Watch, Patents/Designs/Trade Secrets, WHA 2018, WHO

Global Influenza Initiative Celebrates 10 Years, Adds Former WHO Official

21/05/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment

As the annual World Health Assembly opened today, a global initiative for sharing influenza genetic data celebrated its tenth anniversary and announced new senior advisors for international affairs and biosecurity issues, one of which is Marie-Paule Kieny, former World Health Organization Assistant Director-General for Health Systems and Innovation.

Filed Under: IP Policies, Language, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Health & IP, Health Policy Watch, Patents/Designs/Trade Secrets, WHA 2018, WHO

AI Takes Multidimensional Role In Emergency Response And Outbreaks

20/05/2018 by Damilola Adepeju for Intellectual Property Watch 1 Comment

In an age where emphasis on the use of artificial intelligence (AI) for the good of humanity is increasing, last week’s AI for Good Global Summit at the International Telecommunication Union (ITU) brought leading experts together to demonstrate the multidimensionality of AI in emergency response and outbreaks, as well as in risk reduction.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Development, English, Health Policy Watch, ITU/ICANN, Innovation/ R&D, New Technologies, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer

Five Years After The Indian Supreme Court’s Novartis Verdict

20/05/2018 by Patralekha Chatterjee for Intellectual Property Watch 13 Comments

On 1 April 2013, in a packed room inside India’s Supreme Court, a magnificent building in Indo-British architectural style, two judges delivered a verdict that impacted the national and global conversation about patents and patients. India’s apex court delivered a 112-page landmark judgement which dismissed Swiss pharma giant Novartis AG’s appeal for a patent for its life-saving cancer drug marketed under brand name Glivec in most parts of the world. The Novartis case triggered a hugely polarising discourse around the world about a key feature of India’s patent regime.

Filed Under: IP Policies, Language, Themes, Venues, Asia/Pacific, English, Europe, Health & IP, Health Policy Watch, IP Law, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, Regional Policy, Supported By, TRIPS Flexibilities

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 7
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2021 · Global Policy Reporting